• Publications
  • Influence
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European
ABCD : Appropriate Blood pressure Control in Diabetes ABI : ankle–brachial index ABPM : ambulatory blood pressure monitoring ACCESS : Acute Candesartan Cilexetil Therapy in Stroke Survival ACCOMPLISHExpand
  • 4,991
  • 230
  • Open Access
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
99mTc : technetium-99m 201TI : thallium 201 ABCB1 : ATP-binding cassette sub-family B member 1 ABI : ankle-brachial index ACC : American College of Cardiology ACCF : American College of CardiologyExpand
  • 2,975
  • 122
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial
In this position statement of the ESC Working Group on Myocardial and Pericardial Diseases an expert consensus group reviews the current knowledge on clinical presentation, diagnosis and treatment ofExpand
  • 998
  • 98
  • Open Access
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed inExpand
  • 1,854
  • 63
  • Open Access
2015 ESC Guidelines for the diagnosis and management of pericardial diseases
ADA : adenosine deaminase AMI : acute myocardial infarction ANA : anti-nuclear antibody bFGF : basic fibroblast growth factor CK : creatine kinase CMR : cardiac magnetic resonance CMV :Expand
  • 625
  • 35
  • Open Access
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
Background  Fabry disease is a rare X‐linked disorder caused by deficient activity of the lysosomal enzyme α‐galactosidase A. Progressive accumulation of the substrate globotriaosylceramide in cellsExpand
  • 596
  • 27
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic
Authors/Task Force Members: Franz-Josef Neumann* (ESC Chairperson) (Germany), Miguel Sousa-Uva* (EACTS Chairperson) (Portugal), Anders Ahlsson (Sweden), Fernando Alfonso (Spain), Adrian P. BanningExpand
  • 2,842
  • 16
  • Open Access
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on
In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our recent understanding ofExpand
  • 301
  • 13
  • Open Access
Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up.
OBJECTIVES The purpose of this research was to study long-term left ventricular (LV) adaptations in very-high-level endurance athletes. BACKGROUND Knowledge of cardiac changes in athletes, who areExpand
  • 176
  • 13
Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.
AIMS Anderson-Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. The Fabry Outcome Survey is a European database designedExpand
  • 252
  • 12